Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference
Osmotica Holdings US LLCFebruary 18, 2021 GMT
BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference as follows:
Date:
Webcast:
About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Cybin Inc. Releases Financial Highlights and Provides Business Update
Successful bought deal offering brings total capital raised to-date to approximately $90 million Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines – Adelia Therapeutics acquisition expands scientific team, IP portfolio and diversifies development pipeline Partnership with Kernel provides access to neuroimaging … Successful bought deal offering brings total capital raised to-date to approximately $90 million Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines – Adelia Therapeutics acquisition expands scientific team, IP portfolio and diversifies development pipeline Partnership with Kernel provides access to neuroimaging technology, enabling the potential quantification of psychedelic therapeutics –
Cybin Inc Releases Financial Highlights and Provides Business Update apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cybin to Provide Business Update on February 17, 2021 Conference Call
Cybin Inc. a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will conduct a conference call and webcast to review its financial results and provide a business update as follows: A replay of the conference call will be available for two weeks after the call’s completion by dialing 512-2921 or 317-6671 . The conference ID for the … Date A replay of the conference call will be available for two weeks after the call’s completion by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International). The conference ID for the replay is 13716476. The archived webcast will be available for 30 days on: www.cybin.com/investor-relations .